Allurion Technologies Inc(ALUR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 4:00 PM ET (Korea 10/24 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -7.33 | Insider Own | 12.77% | Shs Outstand | 12.3M | Perf Week | - |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 68.86% | Insider Trans | -0.2% | Shs Float | 10.7M | Perf Month | -38.99% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.61 | Inst Own | 33.91% | Short Float | 9.95% | Perf Quarter | -59.33% |
| Income | -0.03B | P/S | 0.48 | EPS this Y | 74.77% | Inst Trans | 2.36% | Short Ratio | 0.4 | Perf Half Y | -69.36% |
| Sales | 0.02B | P/B | - | EPS next 5Y | 52.56% | ROA | -93.92% | Short Interest | 1.07M | Perf YTD | -45.44% |
| Book/sh | -10.68 | P/C | 1.34 | EPS past 3/5Y | - -618.79% | ROE | - | 52W High | -83.94% ($4.18) | Perf Year | -73.79% |
| Cash/sh | 0.5 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 2.87% ($0.65) | Perf 3Y | -99.74% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 39.93% | Gross Margin | 57.97% | Volatility(W/M) | 27.98% 17.88% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.06 | Sales Y/Y TTM | -50.49% | Oper. Margin | -215.48% | ATR (14) | 0.22 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.94 | EPS Q/Q | - | Profit Margin | -187.87% | RSI (14) | 35.69 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.26 | Sales Q/Q | - | SMA20 | -36.97% ($1.06) | Beta | -0.28 | Target Price | $5.5 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -49.33% ($1.32) | Rel Volume | 0 | Prev Close | $0.67 |
| Employees | 137 | LT Debt/Eq | - | EPS/Sales Surpr. | 22.34% 24.6% | SMA200 | -66.34% ($1.99) | Avg Volume(3M) | 2.67M | Price | $0.67 |
| IPO | 2021/3/29 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
🩺 Allurion Technologies (ALUR) is a wellness healthcare company that designs and develops a swallowable, water-filled intragastric balloon medical device for weight loss, which is placed in the stomach without the need for surgery or anesthesia, along with a weight management platform.
Over the past 1 year, on the lower side
84% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
ALUR has weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +74.8% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $48. Peers typically go for $204.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -99.7%.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 33.9%.
Tap to view numbers
It ranks #122 of 144 in the industry
Based on market cap of $8M.
NMTC#121 NeuroOne Medical Technologies Corp $8M PER - ALUR#122 Allurion Technologies Inc $8M PER - 
AEMD#122 Aethlon Medical Inc $8M PER - 
BMRA#123 Biomerica Inc $8M PER - 
TNON#124 Tenon Medical Inc $6M PER - 
FAQ
What kind of company is ALUR?
ALUR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ALUR?
The market cap of ALUR is approximately $8M, ranking 5,526 within its sector.
What is the 52-week high and low for ALUR?
ALUR has recorded a 52-week high of $4.18 and a low of $0.65.
